Preparation and Characterization of Salmon Calcitonin-biotin Conjugates

ÇETİN M., Youn Y. S., ÇAPAN Y., Lee K. C.

AAPS PHARMSCITECH, cilt.9, sa.4, ss.1191-1197, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 4
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1208/s12249-008-9165-2
  • Dergi Adı: AAPS PHARMSCITECH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1191-1197
  • Anahtar Kelimeler: biotinylation, Caco-2, MALDITOF-MS, oral delivery, salmon calcitonin, ORAL PEPTIDE DELIVERY, IN-VIVO EVALUATION, ABSORPTION, STABILITY, TRANSPORT, PERMEABILITY, NANOCAPSULES, DISPOSITION, PEGYLATION, BEHAVIOR
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

This study was performed to prepare and characterize the biotinylated Salmon calcitonin (sCT) for oral delivery and evaluate the hypocalcemic effect of biotinylated-sCTs in rats. Biotinylated sCTs was characterized by using high performance liquid chromatography ( HPLC) and MALDITOF-MS. The effect of biotinylation on permeability across Caco-2 cell monolayers was examined. Their hypocalcemic effect was determined in rats. Mono- and di-bio-sCTs were separated by reverse phase HPLC. The molecular weights of mono-bio-sCT and di-bio-sCT were determined to be 3,660.5 and 3,900.2 Da, respectively. The permeability of biotinylated-sCTs across Caco-2 cell monolayers was observed with a significant enhancement compared with sCT. Intrajejunal (ij) administration of mono-bio-sCT and di-bios-CT resulted in sustained reduction in serum calcium levels, with a maximum reduction (% max(d)) of 21.6% and 30% after 4 h and 6 h of application, respectively. The biotin conjugation of sCT may be a promising strategy for increasing the oral bioavailability of sCT and achieving sustained calcium-lowering effects.